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The U2AF35-like ZRSR1 has been implicated in
the recognition of 30 splice site during spliceosome
assembly, but ZRSR1 knockout mice do not
show abnormal phenotypes. To analyze ZRSR1
function and its precise role in RNA splicing, we
generated ZRSR1 mutant mice containing trun-
cating mutations within its RNA-recognition
motif. Homozygous mutant mice exhibited severe
defects in erythrocytes, muscle stretch, and sper-
matogenesis, along with germ cell sloughing
and apoptosis, ultimately leading to azoospermia
and male sterility. Testis RNA sequencing (RNA-
seq) analyses revealed increased intron retention
of both U2- and U12-type introns, including U12-
type intron events in genes with key functions
in spermatogenesis and spermatid development.
Affected U2 introns were commonly found flank-
ing U12 introns, suggesting functional cross-
talk between the two spliceosomes. The splicing
and tissue defects observed in mutant mice
attributed to ZRSR1 loss of function suggest a
physiological role for this factor in U12 intron
splicing.This is an open access article under the CC BY-NINTRODUCTION
Alternative splicing (AS) of messenger RNA precursors (pre-
mRNAs) is one of the mechanisms whereby a single gene pro-
duces distinct mRNAs, contributing to proteome diversity in
complex organisms (Nilsen and Graveley, 2010). Alterations in
AS are often associated with disease (Daguenet et al., 2015;
Scotti and Swanson, 2016). Ninety-five percent of multi-exon
mammalian genes undergo AS (Pan et al., 2008; Wang et al.,
2008). The splicingmachinery comprises five small, nuclear ribo-
nucleoprotein particles (snRNPs). The major splicing machinery
(termed U2 spliceosome, composed of U1, U2, and U5/4/6
snRNPs) removes the majority of introns, while the minor
(or U12) spliceosome (composed of U11, U12, U5/4atac/6atac
snRNPs) removes <0.5% of all introns (Burge et al., 1998).
U12-type introns coexist with U2-type introns in essential genes
(Patel and Steitz, 2003). Splicing factors ZRSR1/2 have been
implicated in 30 splice site recognition of both U2 and U12 introns
(Shen et al., 2010). Recent sequencing studies have revealed
frequent somatic ZRSR2 mutations in hematological malig-
nancies such as myelodysplastic syndrome (MDS) (Madan
et al., 2015). However, the physiological role of ZRSR1 remains
unclear.
Zrsr1 is an intronless gene located in mouse chromosome
11 and human chromosome 5. Murine Zrsr1 is a retrotransposed
copy of X-linked Zrsr2. Zrsr1 is located within an intron of
Commd1 (Figure 1A) and is paternally expressed in the placentaCell Reports 23, 143–155, April 3, 2018 ª 2018 The Author(s). 143
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Diagrams of Zrsr1 Gene Structure
and Mutations Produced by Zinc Finger-
Mediated Mutagenesis in Transgenic Mice
(A) The Commd1 gene consists of three exons
(vertical bars) and the imprinted gene, Zrsr1,
located in the first intron; a CpG island is shown as
a solid box. Arrows indicate the transcriptional di-
rection of the genes.
(B) Diagram of the Zrsr1 gene with its functional
domains: Zn (zinc finger), RRM (RNA recognition
motif), and RS (arginine-serine rich). The sequence
indicated in the promoter region containing two
GATA regions is repeated 19 times in the closest
promoter region; the sequence also contains a
NRF1 recognizing sequence (double underlined).
(C) Nucleotide deletions produced by zinc finger
nucleases in the transgenic mice lines Zrsr1mu3
and Zrsr1mu6. Blocks indicate nucleotides re-
maining in the mutant, while residues outside the
blocks are deleted nucleotides.
(D) Diagrams of the domains present in the
mutated Zrsr1 proteins in the two transgenic mice
lines. Transgenic mice expressed a mutated short
Zrsr1 protein also containing a Zn domain and part
of the RRM domain. The numbers indicate amino
acids encoded by the mutant proteins.and some adult tissues, while the maternal copy is methylated
and silent (Nabetani et al., 1997). Zrsr1 encodes a protein that
is highly homologous to the 35 kDa subunit of the evolutionarily
conserved heterodimeric splicing factor U2AF. U2AF is
composed of U2AF65 and U2AF35, which play critical roles in
recognition of the polypyrimidine tract and the 30 splice site
AG, respectively. In mammals, U2AF35 is encoded by the
U2AF1 gene and U2AF35-related proteins include U2AF26 (en-
coded by the U2AF1L4 gene), ZRSR1 (also known as U2af1-
rs1) and ZRSR2 (also known as U2af1-rs2) (encoded by the
ZRSR1 and ZRSR2 genes). The 4 proteins are paralogs and
contain 2 CCCH zinc finger motifs and one RNA-recognition
motif (RRM) locatedbetween the twoCCCHdomains (Figure 1B).
U2AF35 familymembers are expressed inmultiple tissues during
development. In most tissues, there is redundant expression of
more than one protein. It has been observed that Zrsr1 knockout
mice do not show an abnormal phenotype (Sunahara et al.,
2000), probably because of the compensatory expression of
one or more of the other 3 paralogs.
To examine the role of ZRSR1 in vivo, we generated Zrsr1
mutant mice containing nonsense mutations in the RNA-recog-
nition motif. These mice show the predicted expression of trun-
cated proteins containing one of the zinc finger (CCCH) domains,
which could potentially exert a dominant negative effect on
ZRSR1 function (Figures 1C and 1D). Homozygous mutants
exhibit severe defects in erythrocyte maturation, muscle
strength, and spermatogenesis, the latter including germ cell
sloughing and apoptosis, ultimately leading to azoospermia
and male sterility. RNA sequencing (RNA-seq) of mouse testis
on day 15 revealed enhanced intron retention as the most144 Cell Reports 23, 143–155, April 3, 2018frequent splicing alteration, affecting mainly U12 introns but
also U2 introns, typically those positioned adjacent to a U12
intron. Further analyses, including rescue experiments in cell cul-
ture, revealed that the mutation gave rise to retention of most of
the U12 introns examined. This study identifies a role for ZRSR1
in U12 intron splicing with effects on spermatogenesis, muscle
strength, and erythrocyte development.
RESULTS
Zrsr1 mRNA Expression in Development and Adult
Tissues
We first analyzed the expression of Zrsr1 during preimplantation
development and in different adult mouse tissues. Zrsr1 was ex-
pressed at the 2-cell stage (at the time of genome activation),
and at the morula and blastocyst stages, when male blastocysts
showed higher Zrsr1 expression levels than female blastocysts
(Figure 2A). Similar expression profiles were observed in the
cow and pig, although the ortholog to Zrsr1 (ZRSR2Y) is only ex-
pressed in male embryos (Bermejo-Alvarez et al., 2010) (Fig-
ure S1A) suggesting a possible role in early sex-developmental
pathways in these species. We detected higher expression of
Zrsr1 in placenta than in embryo on days 8 and 14, without differ-
ences between sexes. In adult tissues, highest expression levels
were observed in the brain, and lower expression levels in other
tissues like epididymis, testis, bone marrow, or muscle (Fig-
ure 2B). In developing testis, Zrsr1 expression was detected in
both Sertoli and spermatogenic cells; peak expression was
observed on days 9 and 15 when the seminiferous epithelium
contains spermatogonia, spermatocytes, and Sertoli cells, and
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Figure 2. RNA Expression of Zrsr1 and Phenotypic Abnormalities of Transgenic Zrsr1 Mutant in Testis, Sperm, and Erythrocytes
(A) Relative expression levels of Zrsr1 during preimplantation embryo development determined by qPCR. Biological triplicate results are presented as
mean ± SEM. Bars with different superscripts differ significantly (p < 0.05); BL, blastocysts.
(B) Relative expression levels of Zrsr1 in fetus and placenta (D8 and D14) and in different adult tissues determined by qPCR. Biological triplicate data for qPCR are
presented as mean ± SEM. Bars with different superscripts differ significantly (p < 0.05).
(C) Relative expression level of Zrsr1 during testis development in germinal cells and Sertoli cells determined by qPCR. Biological triplicate data for qPCR are
presented as mean ± SEM. Bars with different superscripts differ significantly (p < 0.05).
(D) Zrsr1mu and WT littermate testis from 12-week-old mice.
(E) WT (blue, n = 6) and mutant Zrsr1mu (red, n = 6) testes and heart size shown as a percentage of total body weight in 12-week-old mice.
(F) Comparison of average sperm numbers per cauda epididymis (C.E.) in 12-week-old WT (n = 6) and Zrsr1mu mice (n = 6).
(legend continued on next page)
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more reduced expressionwas noted on day 17, whenmost sper-
matogenic cells have reached the spermatocyte stage (Bellve´
et al., 1977) and in adult testis (Figure 2C).
Zrsr1 Mutant Male Mice Display Severe Defects in
Spermatogenesis
It has been reported that Zrsr1 knockout animals do not display
altered phenotypes (Sunahara et al., 2000) possibly because of
the compensating effects of one or more of the other 3 paralogs
(U2af1, U2af1l4, Zrsr2). For this reason, we used a zinc finger
nuclease strategy to generate Zrsr1 mutant mice containing
nonsense mutations in the RNA-recognition motif, thus leading
to a predicted protein which could potentially exert a dominant
negative effect on ZRSR1 function (Figures 1C and 1D). Two
different transgenic mouse lines harboring 4- and 5-nucleotide
deletions (Zrsr1mu3 and Zrsr1mu6, respectively) were therefore
created to produce truncated proteins containing only one zinc
finger domain and part of the RNA-recognition motif (Figures
1C and 1D). Because both lines showed similar phenotypes,
the following phenotypic results refer to the Zrsr1mu3 line, and
all the animals analyzed were homozygous for the mutation.
Expression of the wild-type and mu3 truncated proteins was de-
tected by targeted proteomics (see below).
Male and female transgenic mice developed normally, but
95% of male mutants carrying the mutation in homozygosity
were sterile. The testes of adult mice were smaller than in con-
trols, sperm counts were low (Figures 2D–2F), and sperm
showed abnormalities including neck andmidpiece defects (Fig-
ure 2G, II–VII), head defects (Figure 2G, VII–IX), and tail defects
(Figure 2G, IV–X). Histological observation of Zrsr1mu3 testis re-
vealed some seminiferous tubules arrested at the spermatocyte
stage, few spermatids and spermatozoa (Figures 3A–3C and S2)
germ cell sloughing, and a high level of apoptosis (Figures 3G
and 3H). This ultimately would lead to azoospermia andmale ste-
rility. The epididymis and vas deferens only showed spermato-
cytes, spermatids, and a small amount of spermatozoa (Figures
3D–3F; Video S1). Surprisingly 5% of the young transgenic
mice were fertile until 5–6 months of age and then became ster-
ile, while no correlation was detected between fertility and DNA
methylation status at the imprinting oocyte-specific CpG island
of the promoter and first part of the Zrsr1 exon (Figure 1A), pre-
viously correlated with Zrsr1 expression (Hayashizaki et al.,
1994). Evaluation of the three Zrsr1 paralogs in adult testis re-
vealed increased expression ofZrsr2 in fertilemales (Figure S1B),
suggesting that abnormal escape of Zrsr2 from X chromosome
inactivation (XCI) could be responsible for the low proportion of
Zrsr1mu3 fertile mice. Interestingly Zrsr2 has been reported to
escape XCI in other tissues in mice (Li et al., 2016; Marks
et al., 2015). No difference in mRNA expression was observed
in Sertoli cells (Figure S1C). Immunocytochemical analyses of
MEI1, a gene required for normal meiotic chromosome synapsis
(Sato et al., 2006), in testis of wild-type (WT) and Zrsr1mu3 mice(G) Examples of normal (I) and abnormal (II–XI) sperm isolated from the cauda epi
bright-field microscope). Over 80% of sperm display some type of abnormality i
(IV–X), and immature cells (XI).
(H) Blood smear (methylene blue staining) showing normal erythrocytes (I) inWTm
vacuole), ghost cells (III, indicated by arrow), hypochromic cells (IV, indicated by
146 Cell Reports 23, 143–155, April 3, 2018showed lower percentage of tubules and cells expressing
MEI1 in the mutant (Figure S2). Although normal meiosis could
be observed in some cells of the Zrsr1mu3 testicles, most sper-
matids presented a severely altered nuclear morphology (Fig-
ure S3). Normal histology was observed at day 15 in mutant
mice (Figure S1D).
Rescuing Spermatogenesis in Zrsr1 Mutant Mice
through Spermatogonia Transplantation
To determine whether germinal cells or Sertoli cells were respon-
sible for the spermatogenic defect observed in Zrsr1mu3 we per-
formed spermatogonia transplantations to recipient mice in
which endogenous spermatogenesis had been inhibited by
busulfan treatment (Avarbock et al., 1996). Spermatogonia
from prepubertal WT mice (6 days of age) were transferred to
the busulfan-treated testes of Zrsr1mu adult mice and vice versa.
Spermatogonia from transgenic mice with EGFP-tagged X chro-
mosomes (Nakanishi et al., 2002) were transferred into Zrsr1mu
mice (Figures S4A and S4C) and spermatogonia from double
transgenic mice carrying EGFP and Zrsr1mu alleles transferred
into WT mice (Figures S4B and S4D). As expected, busulfan-
treated testes lacked germ cells but contained Sertoli cells lining
the seminiferous tubule. However, after donor cell transplanta-
tion from either WT or Zrsr1mu mice (n = 17 and n = 31, respec-
tively), green fluorescent tubules were found containing germ
cell elements (n = 11 and n = 25 showed GFP-positive cells in
Zrsr1mu andWT recipientmouse testes, respectively) (Figure S4).
However, while WT spermatogonia transplanted in Zrsr1mumice
were able to produce spermatozoa (Figures S4A, S4C, and S4E–
S4H), Zrsr1mu spermatogonia colonized seminiferous tubules
but did not produce spermatozoa (Figures S4B, S4D, S4I, and
S4J). These results indicate that germinal cells are affected in
Zrsr1mu mice, and mutant Sertoli cells are able to recover the
spermatogenesis capacity of WT transplanted spermatogonia.
Zrsr1 Mutant Male Mice Feature Severe Red Blood Cell
and Muscle Strength Defects
Among the 4 U2AF35-related splicing factors (U2af1, U2af1l4,
Zrsr1, Zrsr2), Zrsr1 was found to show the highest mRNA levels
in erythrocytes fromWT and Zrsr1mumice (Figure S5A). Hemato-
logical evaluation showed that Zrsr1mumice had fewer red blood
cells, a lower amount of hemoglobin, and lower hematocrit
(Table S2), without differences in erythrocyte volume, hemoglo-
bin content, and erythrocyte hemoglobin. Red blood cell
morphology was also affected: 75% of males (n = 20) showed
20%–25% of erythrocytes with different abnormalities (Fig-
ure 2H), mostly blister cells, ghost cells, hypochromic cells,
and echinocyte cells (Figure 2H). These data indicate a role for
Zrsr1 in erythrocyte production and maturation. In addition,
Zrsr1mumice showed increased numbers of lymphocytes, which
could be attributed to lymphocyte leukemia, although the ani-
mals appeared healthy.didymis in Zrsr1mumice (stained with Diff-Quik and observed under a standard
ncluding neck and midpiece defects (II–VII), head defects (VII–IX), tail defects
ice and some abnormalities in Zrsr1mumice like blister cells (II, arrow indicates a
arrow), and echinocytes (V, indicated by arrow).
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Figure 3. Histology of WT and Transgenic
Mice Testis at 3–4 Months of Age from
Testis, Epididymis, and Efferent Ducts
(A) HE staining of a WT testis section. Scale
bar, 40 mm.
(B) HE staining of a Zrsr1mu testis section showing
severe disruption of seminiferous tubule architec-
ture. Scale bar, 100 mm.
(C) Magnification of a Zrsr1mu testis section. Scale
bar, 40 mm.
(D) HE staining of the cauda epididymis in a section
from a WT animal. Scale bar, 100 mm.
(E) HE staining of the caput epididymis containing
immature germ cells in a Zrsr1mu animal. Scale
bar, 50 mm.
(F) HE staining of efferent ducts from Zrsr1mu that
appear empty or containing immature germ cells.
Scale bar, 50 mm.
(G) Hoechst, TUNEL staining, and merge of
testis sections from WT and Zrsr1mu showing
apoptotic cells in the seminiferous tubules. Scale
bar, 100 mm.
(H) Mean ± SEM (n = 6) apoptotic cells in each
seminiferous tubule of WT and Zrsr1mu mice.mRNA expression analysis of the 4 splicing factors (U2af1,
U2af1l4, Zrsr1, Zrsr2) in the quadriceps femoris of WT and
Zrsr1mumice revealed the higher expression of U2af1 compared
to the remaining paralogs (Figure S5B) and also the higher
expression of this gene in mutant mice compared with WT
mice (Figure S5B). Motor performance/coordination (balance
beam) tests in Zrsr1mu revealed no differences with WT mice at
both 4 and 10 months of age. However, Zrsr1mu mice showed
significant deficits in grip strength in wire-hang tests relative to
WTanimals at 4, but especially, at 10months of age (Figure S5C),
suggesting age-related loss of muscle function. Mutant miceCshowed an increase in the number of
fibers of larger cross-sectional area, an in-
crease in average fiber area in the quadri-
ceps femoris (Figure S5E) and a reduction
in the total number of fibers (Figure S5E).
No other histological alterations were
observed in either muscle structure or
collagen amount (Figure S5D).
To explore whether the reducedmuscle
strength could be related to skeletal
muscle calcium content, we determined
total intracellular Ca2+ for the extensor
digitorum longus (EDL) and tibialis
anterior using Ca-dependent UV absor-
bance spectra of the Ca2+ chelator 1,2-
bis(2-aminophenoxy)ethane-N,N,N0,N0-
tetraacetic acid (BAPTA) (Lamboley et al.,
2015). We found higher EDL muscle Ca2+
contents in Zrsr1mu mice (Figure S5F). In
Fluo-4 calcium assays, Ca2+ releases
from sarcoplasmic reticulum (SR) after
transient hypo-osmotic stress were
significantly reduced in Zrsr1mu mice(Park et al., 2014) (Figure S5G) suggesting that these abnormal-
ities in Ca2+ flux across the sarcolemma could be the reason for
the reduced muscular strength shown by the mutant mice.
ZRSR1mu3 Protein Cannot Compensate for the Loss of
ZRSR Function
To directly assess the function of the truncated ZRSR1mu3 pro-
tein, reconstitution experiments were conducted. Endogenous
ZRSR1 and ZRSR2 proteins were small interfering RNA
(siRNA)-knocked down in HEK293 cells and tetracycline used
to induce the expression of N-terminally V5-tagged humanell Reports 23, 143–155, April 3, 2018 147
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Figure 4. Reconstitution System Reveals
that ZRSR1mu3 Is Defective in U12 Intron
Splicing
(A) Experimental design and protein expression.
Timeline of ZRSR proteins knock down, tetracy-
cline-inducible expression of ZRSR1, and protein
variants and RNA isolation. Lower panels: western
blot analysis of ZRSR protein expression (arrow-
head indicates endogenous ZRSR1 and ZRSR2,
and siRNA-resistant human ZRSR1 [lanes 3 and 4],
colored asterisks indicate mZrsr1, ZRSR1mu3 and
mZrsr1truncated protein, which display limited
reactivity with anti-human ZRSR2 antibody), re-
combinant V5-tagged expression and tubulin as
loading control. The positions of molecular mass
markers are indicated on the right.
(B) RT-PCR analysis of CEP164 U12 intron 32
retention. RNA samples from the reconstitution
assays shown in (A) were analyzed using primers
complementary to the exons flanking the intron.
The position of intron retention and spliced PCR
products after acrylamide gel electrophoresis are
indicated. Lower panel shows the quantification of
the percentage of intron retention for six biological
replicates.
(C and D) Equivalent analyses to (B), for U12 intron
7 of RFX5 (C) and intron 4 of MIOS (D) genes.
The values are the average ± SD (error bars), n = 6,
*p < 001 by two-way ANOVA followed by Tukey’s
post hoc test.
(E) Immunoprecipitation-western blotting (IP-WB)
analysis to detect interaction of V5-tagged ZRSR1
with SF3B1 and ZCRB1. Whole cell lysates from
the reconstitution assays shown in (A) were used
for IP.ZRSR1, mouse ZRSR1, ZRSR1mu3, or a truncated ZRSR1 pro-
tein corresponding to the N-terminal 219 amino acids. Each pro-
tein was expressed from the same single genomic locus in stable
cells lines constructed by targeted flip-in genome editing. In
these cell lines, the exogenous proteins were mostly expressed
at levels 3- to 4-fold higher than endogenous ZRSR1 and ZRSR2
proteins, although ZRSR1mu3 accumulated at comparatively
lower levels (Figure 4A), suggesting lower protein accumula-
tion/stability of ZRSR1mu3 compared to the WT protein, likely
contributing to the mutant phenotypes. RNA was isolated 24 hr
after tetracycline induction, and the splicing of several U12 in-148 Cell Reports 23, 143–155, April 3, 2018trons was examined by RT-PCR. Consis-
tent with prior reports of mis-splicing of
U12 introns in patients with myelodys-
plastic syndrome (MDS) (Madan et al.,
2015) with ZRSR2 mutations, the deple-
tion of ZRSR proteins led to enhanced
retention of the Cep164 U12 intron (Fig-
ure 4B, compare lanes 1 and 2). Similar
results were obtained for other U12 in-
trons of the Rfx5 or Mios genes (Figures
4C and 4D and see below). These effects
were rescued upon expression of human
or mouse ZRSR1 proteins (compare lanes
2 with 4 and 6 in Figures 4B–4D), but notby the expression of ZRSR1mu3 nor of the slightly shorter trun-
cated ZRSR1 (lanes 8 and 10 in Figures 4B–4D). Collectively,
these results suggest that ZRSR1mu3 protein is defective at pro-
moting U12 intron splicing. Interestingly, the expression of
ZRSR1mu3 or the truncated (219 amino acids) ZRSR1 exa-
cerbated the effect of ZRSR-protein knock down in the
Cep164 intron (Figure 4B, compare lanes 2 with 8 or 10), sug-
gesting the mutant exerts a dominant-negative effect in some
substrates.
To start analyzing the molecular mechanisms behind these
observations, we carried out immunoprecipitation and western
Figure 5. RNA-Seq Analysis of Gene
Expression and Alternative Splicing Alter-
ations in Zrsr1mu3 Mice Testis
(A) Scatterplot of cRPKM of Zrsr1 mu3 testes
compared with controls at day 15. Blue dots
represent significantly downregulated transcripts,
while red dots show significantly upregulated
transcripts (p < 0.01, fold-change of average
cRPKM > 0.4). Grey dots indicate unchanged
transcripts. cRPKM represents average of 4 WT
and 5 Zrsr1 mu3 samples.
(B) Distribution of categories of alternative splicing
(AS) events differing in Zrsrs1mu3 versus WT
mouse testis, without (left) or normalized (right) to
the overall distribution of the event categories in
mouse transcriptomes. Numbers of each class of
event are indicated in parenthesis.
(C) Log values of fold enrichment and –log of fold
enrichment p values are provided for each AS
category in the lower panel. CE, cassette exons;
A3SS, alternative 30 splice sites; A5SS, alternative
50 splice sites; MXE, mutually exclusive exons; RI,
retained introns.blot analyses using anti-V5 antibodies in the context of the
reconstitution experiments described above. The results re-
vealed that both the WT and mutant protein interact with
SF3B1, a core component of spliceosome required for branch
point recognition at 30 splice sites of U2 and U12-type introns,
and with ZCRB1, a component of the minor spliceosome,
although the interactions were somewhat reduced in the mu-
tants, with the exception of the interaction between ZCRB1
and ZRSR1mu3 (Figure 4E). As expected, interactions were
more apparent when the endogenous ZRSR1 and ZRSR2 pro-
teins were knocked down.
Given our failure to generate antibodies able to detect endog-
enous mouse ZRSR1, we attempted to detect the presence of
WT and mutant ZRSR1 in immunoprecipitates of ZCRB1 from
mouse testes by targeted proteomics. Immunoprecipitation
using anti-ZCRB1 antibodies followed by parallel-reaction moni-
toring (PRM) identified peptides corresponding to ZRSR1 both in
WT and ZRSR1mu3 testes, demonstrating that both the WT and
the truncated mutant proteins are indeed expressed (Figure S6).
U12 Intron Retention Is the Most Frequent Splicing
Alteration Observed in Zrsr1mu3 Mouse Testis
To determine the molecular basis for the spermatogenesis de-
fects observed in Zrsr1mu3 mice, we undertook RNA-seq ana-
lyses of testes from 4 WT and 5 Zrsr1mu3 animals on day 15,
immediately after Zrsr1 expression peaks in developing testis,
when the majority of germ cells are at the spermatocyte stage
in both WT and Zrsr1mu3 animals (Figure 2C). The expression
of the other 3 paralogs inWT and Zrsr1mu3mice was comparableC(Figure 5A). We examined splicing events
that were modified in Zrsr1mu3 mouse
testis using MISO software (Katz et al.,
2010). In total, 281 alternative splicing
events were identified as modified with
a minimum difference in percent splicedin (DPSI) of 10%. All categories of alternative splicing (AS) events
were affected (Figure 5B). However, once normalized according
to the overall distribution of AS events in themouse, intron reten-
tion (IR) was the most significantly affected category (44%) (Fig-
ures 5B and 5C).
Altered splicing events were further examined using software
developed by our group (https://github.com/ppapasaikas/
SANJUAN/tree/master/perllib), which can be used to identify
and annotate novel, non-annotated events, and quantify differ-
ences in the use of competing junctions and retained introns.
We identified 234 IR events that were modified in Zrsr1mu3 testis
(Table S3) displaying fold changes in intron expression jlogFC
(WT/mu3)j > 0.7 (Experimental Procedures). Intron retention ratio
(IRR) values ranged from 0% to a maximum of 64.1%, although
most of the IR events (79.5%) displayed an IRR of <10%.
Likewise, the majority (86.3%) of IR events showed <10% differ-
ence in IRR (DIRR) between WT and Zrsr1mu3 mice (Figure S7A),
although larger IRR/DIRR values may be difficult to detect
due to efficient nuclear and cytoplasmic degradation of non-
spliced RNA.
Because human ZRSR2 has been implicated in both U2 and
U12 intron splicing (Shen et al., 2010), we distinguished between
these two intron classes. First, we updated the U12 intron data-
base using the mouse genome mm10 (Experimental Proced-
ures; Table S4). This resulted in the identification of 647 U12
introns (466 GT/AG and 181AT/AC). Thirty-six percent of
increased IR events observed in Zrsr1mu3 mice (84 out of 234
events) corresponded to the U12 class of introns, a very signifi-
cant (>70-fold) enrichment over the overall proportion of U12ell Reports 23, 143–155, April 3, 2018 149
Figure 6. U12 and U2 Intron Retention in
Zrsrs1mu3 Mice and Interplay between
Introns Spliced by the Major and Minor
Spliceosomes
(A) Number and fold changes of intron retention in
Zrsr1mu3 compared to WT mouse testis (measured
as log2 ratio of intron read counts in Zrsr1mu3
versus WT) for different intron categories, as indi-
cated.
(B) Distribution of the locations of affected U2 in-
trons in Zrsr1mu3 mice relative to U12 introns pre-
sent in the same gene.
(C) Minigene splicing assays indicate that splicing
of U12 intron 5 influences U2 intron 4 splicing. Top:
diagram of the exon/intron structure of the
genomic region included in the Rfx5 minigene.
Middle: RT-PCR analysis of minigene-derived
transcripts isolated from HEK293 cells transfected
with the indicated constructs (WT, WT sequence;
Intron 5, deletion of intron 5; Intron5 > MINX,
construct in which Rfx5 intron 5 was replaced with
a U2 intron from an efficiently spliced adenovirus
major-late promoter transcript intron). The posi-
tions of the different spliced/partially spliced
products are indicated. Bottom: quantification of
the percentage of intron 4 (U2) and intron 5 (U12)
splicing for five independent biological replicates.
The values are the average ± SD (error bars), p <
0.01 versus WT minigene (t test).introns in the mouse transcriptome (0.5%) (Figure 6A). Among
the 573 genes containing U12 introns (in total 647 introns) in
the mouse genome, 522 genes (corresponding to 589 U12
introns) were expressed in WT and/or Zrsr1mu3 testis
(cRPKM >1). Thus, 14.3% (84 out of 589 introns) of U12 introns
expressed in testis were affected in Zrsr1mu3 mice. These find-
ings suggest a specific role in U12 intron splicing for ZRSR1
that cannot be provided in mouse testis by any of the other 3
paralogs.
Twenty-three percent (53 out of 234 events) of the IR events
corresponded to U2 introns within U12-containing genes.
Remarkably, 77% (41 out of 53 U2 introns) of these are located
immediately upstream or (more commonly) downstream of the
U12 introns, suggesting mutual influences between neighboring
U12 andU2 introns (Figures 6A,middle panel, and 6B). In fact, 13
out of the 41corresponding adjacent U12 introns were also iden-
tified asmore retained in Zrsr1mu3mice. U2 IRwas also observed
in genes lacking U12 introns (36% of the events), although these
changes in IR were generally reduced over those detected in the
affected U12 introns (Figures 6A, compare left and right panels,
and S7A). In contrast, the distribution of IR changes was similar
between affected U12 introns and U2 introns within U12 intron-
containing genes, with most events featuring a more than 2-fold
increase in intron read counts in Zrsr1mu3 mice (Figure 6A,
compare left and central panels). Surprisingly, 36.1% of the U2150 Cell Reports 23, 143–155, April 3, 2018introns affected showed less retention
than in WT mice (Figures 6A, right panel,
and S7A), which could reflect either a
direct repressive effect of ZRSR1 or indi-
rect effects of the mutant protein on asubset of introns. The majority (93.3%) of the genes displaying
elevated IR showed no detectable changes (jLog2FCj < 0.5) in
overall expression.
To validate the U12 intron splicing abnormalities observed in
Zrsr1mu mice, we analyzed U12 IR events identified with MISO
by semiquantitative RT-PCR of RNAs from Zrsr1mu3, Zrsr1mu6
and control WT adult testes. Significant increases in U12 IR
were detected in both Zrsr1mu3 and Zrsr1mu6 mice compared
with WT for all 7 U12 introns examined (Figure S7B). Increases
in IR ranged from 2- to 30-fold, with cases in which IR corre-
sponded to >30% of the total transcripts. Similar results were
obtained by qRT-PCR (Figure S7C), although fold IR change es-
timates were somewhat higher using this method. IR changes
were similar for Zrsr1mu3 and Zrsr1mu6 mice, suggesting that
both mutant proteins are non-functional, consistent with the
similar associatedmice phenotypes. As predicted byMISO anal-
ysis, we observed no changes in the retention of Gpaa1 and
Hdac10 U2 introns.
Our SANJUAN software also detected other alternative
splicing differences between WT and Zrsr1mu3 mice, including
268 skipped exons, 57 alternative 30 splice sites, and 19 alterna-
tive 50 splice sites with a minimum DPSI of 15%. Among these,
we observed in Zrsr1mu3 mice 15 aberrant splicing events asso-
ciatedwith U12 introns (Table S3). On several occasions, U2 50 or
30 splice sites were activated within an exon or a U12 intron or
within the flanking U2 introns. These sites were spliced to (U2)
30/50 splice sites resulting in partial IR, truncated exons and/or
exon skipping (Figure S8A). These observations further support
the possibility of an interplay between major and minor
spliceosomes.
Candidate genes containing affected U12 introns that could
underlie the spermatogenesis defects include Mei1, Catsper2,
Htt, Catsper1, Spo11, Diap2, Inpp5B, Oca2, Spag16, and
Taf7L. Spo11 and Mei1 are required for chromosome synapsis
in meiosis I and their deletion results in arrest at the zygotene
stage (Baudat and Keeney, 2001; Libby et al., 2002; Smirnova
et al., 2006). As shown in Figures 3 and S2, some seminiferous
tubules in Zrsr1mu3 testis arrested at the spermatocytes stage,
correlating with reduced Mei1 expression. Thus, increased U12
IR in Mei1 (as well as Spo11, in which we also identified a U12
intron retention event) could contribute to the observed meiotic
arrest (Figure S8C). In addition, the timing of arrest at the zygo-
tene stage is consistent with meiotic sex chromosome inactiva-
tion (MSCI), which occurs during prophase I in themale germline.
The expression of 82% of all X-linked genes including Zrsr2 has
been reported as suppressed via MSCI (Mueller et al., 2008;
Namekawa et al., 2006). The loss of Zrsr1 could be offset by
Zrsr2 expression before MSCI, and the phenotype in Zrsr1mu3
testis may conceivably emerge after MSCI, at the time when
Zrsr2 is silenced. Low sperm counts were observed in Zrsr1mu3
testis (Figure 2F) indicating that some spermatocytes success-
fully go through meiosis, most probably supported by the re-
maining levels of ZRSR2 protein after MSCI. Gene expression
analysis identified only 131 genes (67 downregulated and 64
upregulated) differentially expressed in Zrsr1mu3 mouse testis
compared with the WT (log2 ratio of cRPKM >0.4 and p < 0.01,
Figure 5A; Experimental Procedures). Seventeen out of 40 genes
examined (42%) were validated as differentially expressed in
Zrsr1mu3 testis (Figure S8D). Interestingly, 65% of the validated
downregulated genes contain U12 introns, suggesting that U12
intron retention in those genes leads the transcript to enter the
nuclear and cytoplasmic degradation pathway and results in
the decrease of total expression of the gene (Figure S8D).
qRT-PCR of the 10 U12 intron-containing genes classified as
relevant for spermatogenesis revealed reduced expression of to-
tal transcripts in all the 10 genes to 2567% in Zrsr1mu3 testis at
day 15, although they were filtered out from RNA-seq analysis
due to the individual variation (Figure S8E). Taken together, these
data suggest that the defect in spermatogenesis in Zrsr1mu3
mice could be attributed to mis-regulation of spermatogenesis-
related genes containing U12 introns.
The U12 Intron Reduces the Efficiency of Splicing of the
Upstream U2 Intron in an Rfx5 Minigene
To investigate possible mutual influences between U2 and U12
intron splicing, a minigene containing U12 intron 5 flanked by
U2 introns 4 and 6 of the Rfx5 gene was transfected into
HEK293 cells. RNA was then isolated 24 hr post-transfection
and minigene-derived transcripts detected by RT-PCR (Fig-
ure 6C). Substantial levels of IR were observed both for intron
4 (U2, 45%, corresponding to the upper band in lane 1 in Fig-
ure 6C) and for intron 5 (U12, 70%, corresponding to upper +
middle bands in lane 1 in Figure 6C). As no (U2) intron 4 retentionwas detected in the absence of (U12) intron 5 retention in our
minigene assays (Figure 6C, lane 1), it could be that splicing of
U12 intron 5 affects splicing of U2 intron 4. To test this hypothe-
sis, U12 intron 5 was deleted from the minigene. The results re-
vealed the efficient (95%) removal of U2 intron 4 (Figure 6C,
compare lanes 1 and 2), suggesting that the presence of the
U12 intron blocks the removal of the upstream U2 intron. To
confirm that this effect was indeed related to the presence of a
U12 intron, intron 5 was replaced by an intron from transcripts
derived from the adenovirus major late promoter, which is effi-
ciently spliced by the U2 spliceosome (Figure 6C, lane 3). As in
its absence, the replacement of intron 5 by an efficiently spliced
U2 intron also resulted in efficient U2 intron 4 splicing in this mini-
gene system. These data indicate that inhibition of a U12 intron
exerts an inhibitory effect on splicing of the upstream intron,
thus arguing for mutual functional influences between major
and minor spliceosome machineries.
DISCUSSION
In this study, we report a physiological role of ZRSR1 in erythro-
cyte development, muscular strength, and spermatogenesis, by
examining Zrsr1 mutant mice lacking one of the two zinc finger
domains and part of the RNA-recognition motif (RRM) of the pro-
tein. In addition, as possible explanations for the phenotypes
observed, we identified, using transcriptome analyses, abnor-
malities in the expression and splicing of U12 introns as well as
their adjacent U2 introns.
One of the first questions that arises from our observations is
that, if ZRSR1 is expressed in many tissues, why do the pheno-
typic effects of themutation appear to be restricted to spermato-
genesis, erythrocyte development and muscle strength, and
observed only in homozygous mice. We suggest that the mutant
protein ZRSR1mu exerts its effects mainly in tissues where its
expression predominates over the expression of Zrsr2 or other
paralogs. Consistent with this, expression of the mutant protein
was seen to exacerbate the U12 intron splicing defect only in Zrsr
siRNA-treated cells and only in certain substrates (Figure 4).
Thus, the truncated protein may exert its dominant effects
through abortive interactions with substrate RNAs and/or with
components of the minor spliceosome (Figure 4), which could
be particularly critical for specific subsets of 30 splice sites.
Consistently, zinc finger domains in U2AF35 have been impli-
cated in 30 splice site selection (Ilagan et al., 2015).
The origin and coexistence of two parallel intron types and two
machineries for their removal remains poorly understood, espe-
cially because U12-type introns are present at very low fre-
quencies. Recent findings point to a role of U12-dependent
splicing in development, disease, and cell division (Ko¨nig et al.,
2007; Turunen et al., 2013), indicating essential functions of
U12-type splicing. In addition, it is known that RNA mis-splicing
is the underlying mechanism for several diseases (Chabot and
Shkreta, 2016; Daguenet et al., 2015) including male infertility
(Bao et al., 2014; O’Bryan et al., 2013). Further, somatic muta-
tions in 30 splice site recognition factors, including ZRSR2,
have been attributed a role in myelodysplastic syndrome
(MDS) (Thol et al., 2012; Yoshida et al., 2011) and have been
also linked to splicing defects, including most U12-type intronsCell Reports 23, 143–155, April 3, 2018 151
(Madan et al., 2015). Our RNA-seq analysis of Zrsr1mu3 mouse
testis also revealed greater impact of the mutation on U12 intron
retention compared to U2 intron retention, revealing functional
similarities between Zrsr1 and Zrsr2, consistent with Zrsr1 being
a retrotransposed copy of X-linked Zrsr2.
Our transcriptome and minigene assays revealed an interplay
between neighboring U12 and U2 introns. Most retained U2 in-
trons within U12-containing genes are located immediately up-
stream or downstream of the U12 introns (more commonly and
with more pronounced changes in intron retention when located
downstream; Figure S8B), similar to observations associated
with Zrsr2 mutations in MDS patients (Madan et al., 2015). This
crosstalk is thought to involve effects on exon definition that
could be mediated by SR proteins or other auxiliary factors
(Hastings and Krainer, 2001; Wu and Krainer, 1996). Interest-
ingly, ZRSR2 has been shown to play a role in early 30 splice
site recognition of U12 introns and in the second catalytic step
of U2 intron splicing (Shen et al., 2010). It is possible that
ZRSR1 also has a dual role in both spliceosomes and that the
combined defect in ZRSR1 function is consequently most
noticeable in adjacent pairs of U2/U12 introns. While U12 intron
splicing is enhanced by the presence of flanking U2 introns
(Wu and Krainer, 1996), our Rfx5 minigene assay revealed that
U12 intron retention actively inhibits splicing of the adjacent U2
intron. The removal of U12 introns is generally slower or less effi-
cient than that of U2 introns, resulting in 2-fold higher retention
steady-state RNA levels (Niemela¨ and Frilander, 2014; Patel
and Steitz, 2003; Singh and Cooper, 2012). This difference could
serve as a final check of the mRNA in the cytoplasm for post-
transcriptionally control of the expression of a specific subset
of genes (van den Hoogenhof et al., 2016).
U12-dependent splicing is required for development in hu-
mans, D. melanogaster, A. thaliana, and D. rerio (Markmiller
et al., 2014; Turunen et al., 2013). We have observed the early
expression of Zrsr1 in preimplantation embryos in mice, pigs,
and earlier, in cows (Bermejo-Alvarez et al., 2010). In these
three mammalian species, there are two peaks of Zrsr1
expression during preimplantation development, one at the
time of embryonic genome activation, and the other at the
blastocyst stage, suggesting its important function during
early development. Interestingly, the main cell types that
were affected in Zrsr1mu mice correspond to cells for which
a function for the minor spliceosome has been proposed to
take place in the cytoplasm (Turunen et al., 2013). These
include spermatocytes after nuclear envelope breakdown,
enucleate hemostatic cells (e.g., mature erythrocytes), and
cells capable of rapid response to changes in the local envi-
ronment (e.g., muscle cells).
Spermatogenesis can be divided into a mitotic, a meiotic, and
a haploid phase. Thus, spermatocytes undergo homologous
recombination-mediated crossover and nuclear envelope
breakdown, followed by two consecutive meiotic cell divisions.
The seminiferous tubules of Zrsr1mu mice were arrested at the
spermatocyte stage suggesting a malfunction of Sertoli and/or
germ cells. In our spermatogonia transplantation assays Sertoli
cells from Zrsr1mu mice were able to support spermatogenesis
of WT spermatogonia suggesting that ZRSR1 is essential for
normal germ cell function. According to Schmid et al., (2013),152 Cell Reports 23, 143–155, April 3, 2018the splicing landscape is reprogrammed during mitotic-to-
meiotic transition of themale germ cell cycle. Our results support
an essential role for Zrsr1 in this transition, when transcription of
its principal paralog Zrsr2 is repressed through X chromosome
inactivation during spermatogenesis, and suggest that minor
spliceosome-dependent splicing may be pivotal during meiotic
nuclear envelope breakdown.
We observed that Zrsr1 is the preferentially expressed U2af35
paralog in mature erythrocytes. Consistently, specific upregula-
tion of Zrsr1 and downregulation of U2af1 have been reported
during erythroid differentiation (Grosso et al., 2008). Of note,
our RNA-seq data identified the differential expression of genes
related to iron homeostasis, including Ftmt (ferritin mitochon-
drial), Ftl1 (ferritin light chain 1), Tfrc (transferrin receptor), and
Slc25a37 (solute carrier family 25 mitochondrial iron transporter,
member 37). High intron retention levels in the Slc25a37 gene
and other (particularly RNA processing) genes have been re-
ported during terminal erythropoiesis (Pimentel et al., 2016).
Intron retention in Slc25a37 is thought to provoke abnormal
iron accumulation in MDS erythroblasts (Visconte et al., 2015).
Thus, intron retention may act as a post-transcriptional regulator
of iron homeostasis genes in erythrocytes.
Some measure of muscular weakness is associated with mu-
tations in Ca2+ channels (Cain and Snutch, 2011) although loss of
muscle strength can be caused by several factors, including a
drop in releasable calcium from skeletal muscle SR calcium
stores (Kabbara and Allen, 1999). Interestingly, altered splicing
of the skeletal muscle genes chloride channel gene (Clcn1),
bridging integrator (Bin1), ryanodine receptor 1 (RyR1), myotu-
bularin-related 1 gene (Mtmr1), and sarcoplasmic/endoplasmic
reticulum Ca2+ ATPase (Serca) 1 or 2 seem to contribute to
myotonia, muscle weakness, and impaired calcium homeostasis
(Singh and Cooper, 2012). We noted a significant reduction in
Ca2+ released from the SR in Zrsr1mu mice in response to stress
(Figure S5G), suggesting abnormalities in Ca2+ flux across the
sarcolemma underlying the muscle strength loss observed in
mutant mice. Multiple members of gene families related to
Ca2+ biology and ion channels show clear enrichment in
U12-type introns (Ca2+-dependent phospholipases, calpains,
voltage-dependent Ca2+ channels, and sperm-specific Ca2+
channels, Na+ channels, Na+/K+/Cl/H+ channels, and Cl
channels), suggesting a role for Zrsr1 in regulating U12-type
muscle-specific splicing events. Consistently, we observed mis-
regulation of Tnnt2 (troponin T type 2), whose alternative splicing
results in many isoforms and regulates muscle contraction in
response to alterations in intracellular calcium ion concentra-
tions (Jin et al., 2008). Future analysis of minor splicing in muscle
could provide further insight into the role of splicing defects in
muscle-related diseases. Such a role is well documented for
the major spliceosome (Daguenet et al., 2015; Scotti and Swan-
son, 2016).EXPERIMENTAL PROCEDURES
Generation of Zrsr1 Mutant Mice
Mouse Zrsr1 (NM_011663.3) gene was targeted and five transgenic lines were
successfully generated. Details are provided in the Supplemental Information.
For this study, two lines with 4 and 5 nt deletions were used (Zrsr1mutant lines
3 and 6). Homozygotes were used in all experiments. Zrsr1mu/+ did not differ
phenotypically from Zrsr1+/+mice, and both genotypes were used as controls.
Animal experiments were carried out in strict accordance with the recommen-
dations stipulated in the guidelines of European Community Council Directive
2010/63/EU. Experiments were approved by the Committee on the Ethics of
Animal Experiments of the INIA (permit number CEEA 2012/021).
Gene Expression Analysis: qRT-PCR
RNA extraction and qRT-PCR were conducted following standard protocols
as detailed in the Supplemental Information.
Isolation of Spermatogenic, Sertoli Cells, and Spermatozoa
To isolate spermatogenic and Sertoli cells, mice were euthanized and the
testes were subjected to slight collagenase-trypsin digestions for obtaining
a cell suspension. Overnight culture of this cell suspension allowed to separate
the Sertoli cells (attached to the culture plate) from the spermatogenic cells
(cells in suspension). Detailed protocol can be found in the Supplemental Infor-
mation. Spermatozoa were extracted from epididymis following standard pro-
cedures described in the Supplemental Information.
Muscle Histology and Morphometry
Histological sections were stained with H&E as well as with PicroSirius red
solution. Further description is provided in the Supplemental Information.
Testis Histology, TUNEL Staining, and Sperm Staining
For histological examination, whole mouse testes were fixed in Bouin’s fluid
at 4C overnight, washed in PBS, and then paraffin embedded and H&E-
stained. To detect apoptotic cells, testes were fixed in 10% PFA (neutral buff-
ered, Sigma-Aldrich, MI, USA) and sections (5-mm) were stained using the
TUNEL in situ Cell Death Detection Kit (Roche, Basel, Switzerland) following
the protocol provided by the manufacturer. Scoring of apoptosis frequency
was performed by counting TUNEL fluorescent cells in 20 random seminifer-
ous tubules in 6 WT and 6 mutant mice. Tubule cross-sections were scored
as number of apoptotic cell per seminiferous tubule.
Immunocytochemistry for Mei1 Detection
Dewaxed and rehydrated testis sections were labeled with the primary anti
Mei1 antibody (sc-515359, Santa Cruz Biotechnology, TX, USA) following a
standard procedure (see the Supplemental Information for further details).
Spreading of Spermatocytes and Immunocytology
Spermatocytes were obtained from testes of adult Zrsr1mu males by the dry-
ing-down technique as previously described (Peters et al., 1997) and labeled
with anti SYCP3 (sc-74569, Santa Cruz) or anti g-H2AX (ab-2893, Abcam)
antibodies following a standard immunocytochemical protocol (see the Sup-
plemental Information for further details).
DNA Methylation
DNA methylation was analyzed from 5 fertile and 5 sterile Zrsr1mu/mu mice by
bisulfite conversion followed by PCR amplification, clonation, and sequencing.
Detailed procedure is described in the Supplemental Information.
Complete Blood Counts
Mice were bled into EDTA-containing tubes and complete blood counts and
cytological analysis performed on peripheral blood collected using EDTA-
coated capillaries. Peripheral blood was diluted 10-fold into cold buffer
(HBSS containing 20 mM EDTA) and subjected to automated analysis using
a Bayer Advia120 hematology analyzer. Reticulocyte morphologies were
scored by counting in blood smears stained with new methylene blue
(Sigma-Aldrich, MI, USA) according to the manufacturer’s protocol.
Testicular Germ Cell Preparation and Transplantation
Isolated spermatogenic cells were injected into testes of males pre-treated
with busulfan for germline removal. As a reporter, the transgenic mice strain
XEGFP (Nakanishi et al., 2002) was used. Thus, spermatogenic cells of
Zrsr1mu/mumicewere transferred to testis of will typemice and vice versa. After45 or 60 days colonization of the receipt, testis was evaluated by fluorescent
microscopy. For a detailed protocol, see the Supplemental Information.
Behavior Tests
Balance beam and wire hang test were conducted in WT or mutant mice as
detailed in the Supplemental Information.
Calcium Contents of the Extensor Digitorum Longus and Tibialis
Anterior
Total calcium of digitorum longus (EDL) and tibialis muscles was quantify
following the procedure described elsewhere (Lamboley et al., 2015) and
detailed in the Supplemental Information.
Calcium Flux across the Sarcolemma in Intact Extensor Digitorum
Longus
Ca2+ flux in EDLmuscle was assessed following themethod described by Park
et al., (2014) and detailed in the Supplemental Information.
ZRSR1 Expression Vectors and Stable Cell Lines
Human ZRSR1, mouse Zrsr1, Zrsr1mu3, and mouse Zrsr1 truncated protein
(219 aa) coding sequence tagged with a V5 sequence at the N terminus
(V5-) were cloned in HEK293 cells as described in the Supplemental
Information.
Sample Preparation for Parallel Reaction Monitoring Proteomics
For detection of endogenousmouseZrsr1protein testis lysateswere conducted
to co-immunoprecipitation using anit-ZCRB1 polyclonal antibody A304-697A,
Bethyl Laboratories). Subsequently parallel reaction monitoring (PMR) by liquid
chromatography-tandem mass spectrometry (LC-MS/MS) analysis was con-
ducted following the protocol described in the Supplemental Information.
RNA-Seq Analysis
RNA-seq was performed from the testes of 4 WTmice and 5 knockout mice at
day 15 as described in the Supplemental Information.
Updating the U12 Intron Database
Using mammalian U12 sequences from U12 db (http://genome.crg.es/
cgi-bin/u12db/u12db.cgi), position weight matrices were generated for
the donor, acceptor, and branch sites separately for U12-ATAC and U12-
GTAG introns. These matrices were used to scan the introns of
interest and classify the introns as U2 or U12 introns based on the mapping
score.
RT-PCR for the Detection of U12 Intron Retention in Mouse Testis
and in the Functional Reconstitution Experiments
Mouse testes of WT (n = 4), ZRSR1mu/mu line 3 (n = 4), and ZRSR1mu/mu line 6
(n = 3) were conducted for RT-PCR using a standard protocol. Further details
are provided in the Supplemental Information.
Minigene Assay
The Rfx5 minigene was constructed by subcloning a PCR product of the Rfx5
gene containing exon 4 to 25 nt downstream of exon 7 amplified from mouse
genomic DNA. See the Supplemental Information for further details.
Statistical Analysis
All data were collected from experiments run in triplicate and reported as the
mean ± SEM. All statistical tests were performed using the software package
SigmaStat (Systat Software, CA, USA). Significant differences were
determined based on the Student’s t test (two groups), one-way ANOVA, or
two-way ANOVA followed by Tukey’s post hoc test unless otherwise stated.
Significance was set at p < 0.05.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is
ArrayExpress: E-MTAB-4872.Cell Reports 23, 143–155, April 3, 2018 153
SUPPLEMENTAL INFORMATION
Supplemental Information includes STAR Methods, eight figures, four tables,
and one video and can be found with this article online at https://doi.org/10.
1016/j.celrep.2018.03.028.
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